Drugs-from-chicken eggs firm faces funding crunch
A biotechnology firm pioneering the production of drugs in the eggs of genetically modified chickens said yesterday it had only around one year's funding left and would need to raise more money in
A biotechnology firm pioneering the production of drugs in the eggs of genetically modified chickens said yesterday it had only around one year's funding left and would need to raise more money in